No. THCA is not explicitly legal in Peru, as the country classifies all cannabis derivatives—including THCA—under narcotic regulations enforced by the National Commission for Development and Life Without Drugs (DEVIDA). While medicinal cannabis was legalized in 2017, THCA’s psychoactive potential upon decarboxylation places it in a legal gray area, with imports requiring DEVIDA approval.
Key Regulations for THCA in Peru
- Narcotic Classification: DEVIDA enforces Peru’s Ley N° 30681 (2017), which regulates cannabis derivatives, treating THCA as a controlled substance due to its conversion to THC.
- Licensing Requirements: Any THCA product must secure a special permit from DEVIDA, which scrutinizes THC content thresholds (≤0.2% for exemptions) and intended use (medical/research only).
- Import/Export Restrictions: Unauthorized cross-border movement of THCA triggers penalties under Decreto Legislativo N° 1226 (2015), mandating prior authorization from the Ministry of Health and Customs.
Recent 2026 draft amendments to Peru’s drug policy propose stricter controls on synthetic cannabinoids, potentially expanding scrutiny to THCA-rich products. Enforcement prioritizes unregistered imports, with penalties ranging from fines to imprisonment under Código Penal Artículo 296 (illicit drug trafficking). Local laboratories must adhere to DEVIDA’s Guía Técnica para Cannabis Medicinal (2023), which excludes THCA from standard medicinal exemptions.